Cargando…
Neurovascular damage in experimental allergic encephalomyelitis: a target for pharmacological control
The blood-brain barrier (BBB) is composed of a continuous endothelial layer with pericytes and astrocytes in close proximity to offer homeostatic control to the neurovasculature. The human demyelinating disease multiple sclerosis and the animal counterpart experimental allergic encephalomyelitis (EA...
Autor principal: | Bolton, C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365877/ https://www.ncbi.nlm.nih.gov/pubmed/18472862 http://dx.doi.org/10.1080/09629359791415 |
Ejemplares similares
-
The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis
por: Ge, Shujun, et al.
Publicado: (2012) -
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: THE EFFECT OF 6-MERCAPTOPURINE
por: Hoyer, Leon W., et al.
Publicado: (1962) -
A Critical Role for Lymphotoxin in Experimental Allergic Encephalomyelitis
por: Suen, Winnie E., et al.
Publicado: (1997) -
A study on demyelinating effect of galactocerebroside in experimental allergic encephalomyelitis.
por: Khang, S. K., et al.
Publicado: (1988) -
Cellular events in the induction of experimental allergic encephalomyelitis in rats
Publicado: (1976)